Accounts Receivable turnover ratio remained unchanged during the fourth quarter 2024, compared to the previous quarter at 5.55 pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Nevro 's accounts receivable remained unchanged at 66 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 365 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 2351 to 2929.

What is Receivable Turnover Ratio?
What is Nevro Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVRO Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-9.44 %	2.34 %	7.02 %	17.03 %	0.57 %
Y / Y Revenue Change	-9.01 %	-6.67 %	-4.91 %	5.4 %	2.25 %
Receivable Turnover Ratio (TTM)	5.55	5.55	5.67	5.84	6
NVRO's Total Ranking	# 2929	# 2351	# 1445	# 1965	# 1965
Accounts Receivable average collection period days	66	66	64	62	61
Seq. Receivable Change	1.82 %	-4.94 %	-3.44 %	-3.1 %	15.07 %
Seq. Revenue Change	9.63 %	-6.62 %	1.91 %	-12.78 %	12.45 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 136
Healthcare Sector	# 366
Overall Market	# 2929

Receivable Turnover Ratio Statistics
High	Average	Low
6.9	5.69	5.18
(Dec 31 2014)		(Sep 30 2020)

NVRO Company Profile • Back to NVRO Efficiency Comparisons • Compare NVRO Receivables Turnover Ratio to its Competitors

Financial Statements
Nevro 's Accounts Receivable	$ 72 Millions	Visit NVRO's Balance sheet
Nevro 's Sales TTM	$ 408 Millions	Visit NVRO's Income Statement
Sources of NVRO's Revenues		Visit NVRO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVRO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NVRO's Growth Rates	NVRO's Roa	NVRO's Inventory Turnover Ratio	NVRO's Dividend Comparisons
NVRO's Profitability Ratios	NVRO's Roi	NVRO's Asset Turnover Ratio	NVRO's Dividend Growth
NVRO's Valuation Ratios	NVRO's Roe	NVRO's Financial Strength Ratios	NVRO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Inmed Pharmaceuticals Inc	15.49	$ 4.494 Millions	$ 0.290 Millions
Nexalin Technology Inc	15.48	$ 0.169 Millions	$ 0.011 Millions
Cervomed Inc	15.47	$ 9.738 Millions	$ 0.630 Millions
China Pharma Holdings Inc	15.36	$ 4.529 Millions	$ 0.295 Millions
Waters Corporation	15.20	$ 2,958.387 Millions	$ 194.592 Millions
Zomedica Corp	15.02	$ 27.087 Millions	$ 1.804 Millions
Biofrontera Inc	14.73	$ 63.395 Millions	$ 4.303 Millions
Icu Medical Inc	14.57	$ 2,382.046 Millions	$ 163.441 Millions
Vaxart Inc	14.36	$ 28.700 Millions	$ 1.999 Millions
Seer Inc	14.07	$ 14.055 Millions	$ 0.999 Millions
American Oncology Network Inc	13.67	$ 1,759.484 Millions	$ 128.741 Millions
Medinotec Inc	13.63	$ 7.872 Millions	$ 0.577 Millions
Escalon Medical Corp	13.40	$ 12.169 Millions	$ 0.908 Millions
Chemed Corporation	13.32	$ 2,431.287 Millions	$ 182.485 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	13.23	$ 4.879 Millions	$ 0.369 Millions
Nrc Health	13.22	$ 143.060 Millions	$ 10.824 Millions
Amylyx Pharmaceuticals Inc	13.13	$ 87.371 Millions	$ 6.655 Millions
Patterson Companies Inc	13.08	$ 6,511.680 Millions	$ 497.898 Millions
Qhslab Inc	12.98	$ 2.132 Millions	$ 0.164 Millions
Dyadic International Inc	12.88	$ 3.495 Millions	$ 0.271 Millions
Lftd Partners Inc	12.73	$ 37.325 Millions	$ 2.933 Millions
Rosecliff Acquisition Corp I	12.51	$ 29.581 Millions	$ 2.366 Millions
Co diagnostics Inc	12.07	$ 3.915 Millions	$ 0.324 Millions
Teladoc Health Inc	11.97	$ 2,569.574 Millions	$ 214.724 Millions
Lexicon Pharmaceuticals Inc	11.82	$ 31.081 Millions	$ 2.629 Millions
Corcept Therapeutics Inc	11.79	$ 675.040 Millions	$ 57.262 Millions
Avricore Health Inc	11.67	$ 3.402 Millions	$ 0.291 Millions
Lifeloc Technologies Inc	11.65	$ 8.538 Millions	$ 0.733 Millions
Vsee Health Inc	11.52	$ 10.546 Millions	$ 0.916 Millions
International Stem Cell Corporation	11.43	$ 9.085 Millions	$ 0.795 Millions

Date modified: 2026-10-07T00:41:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.